To examine whether these pathways are affected by endogenous LRRK2 mutations beyond G2019S, and when present in the heterozygous state associated with PD, we assessed different aspects of iron homeostasis in iPSCs from LRRK2 mutation carriers. The gene discussed is LRRK2; the disease is Parkinson disease.